The SVP and chief strategy and development officer at Aquestive Therapeutics discussed the hope to provide both patients and providers with a more favorable, and still efficacious, option for seizure clusters.
Dan Barber, MBA
Advertisement
Articles by Dan Barber, MBA
Advertisement
Latest Updated Articles
Dan Barber, MBA: Advantages of Diazepam Buccal Soluble Film FormulationPublished: December 4th 2018 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Understanding VTX3232’s Effects on Patients with Early-Stage Parkinson Disease
2
2025 CNS Annual Meeting: Top Expert Interviews and Key Takeaways
3
Ocrelizumab’s Encouraging Treatment Effects Across Conception Delivery and Breastfeeding
4
This Week on NeurologyLive® — October 27, 2025
5
